TSPAN32 and systemic lupus erythematosus: Indeed, our findings indicate that TSPAN32 is significantly downregulated in SLE plasmablasts, and its expression inversely correlates with genes involved in various immune-related pathways, including antigen processing and presentation, cell cycle regulation, and type I interferon signaling [9].